Related Experiment Video
Updated: Sep 6, 2025

External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
Stage 1 Hypertension in Nulliparous Pregnant Patients and Risk of Unplanned Cesarean Delivery
Anna Natenzon1, Caitlin W Parrott2, Nihita Manem3
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, St. Francis Hospital, Trinity Health of New England, Hartford, Connecticut.
Objective:
The aim of the study is to determine whether stage 1 hypertension is a risk factor for cesarean at ≥390/7 weeks.
Study Design:
This is a retrospective cohort study of nulliparas delivering at ≥390/7weeks. Exposure was defined as stage 1 hypertension and compared with normotension. The primary outcome was unplanned cesarean. Statistical analysis was performed using SPSS 27.
Results:
Two hundred and fifty patients had stage 1 hypertension and 250 had normotension. Thirty-eight percent of the patients with stage 1 hypertension required cesarean as did 22% of controls (risk ratio [RR]=1.55, 95% confidence interval [CI]: 1.23-1.96, p <0.001). This remained significant after controlling for confounders in a logistic regression (odds ratio [OR]=1.61, 95% confidence interval [CI]: 1.02-2.55, p <0.040). Upon secondary analysis, these results were statistically significant for gestational age ≥395/7 weeks (adjusted odds ratio [AOR]=1.89, 95% CI: 1.05-3.39, p=0.033) but not from 390/7 to 394/7weeks (AOR=0.68, 95% CI: 0.31-1.50, p=0.34).
Conclusion:
In nulliparas, stage 1 hypertension is an independent risk factor for unplanned cesarean.
Key Points:
· Stage 1 hypertension correlates with more cesareans.. · Unplanned cesarean for nonreassuring fetal status correlates with impaired placental function.. · Stages 1 and 2 hypertension carry similar risks..
Related Concept Videos
Hypertension I: Introduction
Hormonal Regulation
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Mitral Valve Prolapse III: Nursing Management

